Table 1 Demographic data of subjects.
Total (N = 5,000,566) | Patients who did not develop TB (n = 4,968,488) | Patients who developed TB (n = 32,078) | p value | |
|---|---|---|---|---|
Age, years | 47.2 ± 14.1 | 47.1 ± 14.1 | 56.1 ± 15.8 | < 0.001 |
Sex, male | 2,732,571 (54.7) | 2,713,664 (54.6) | 18,907 (58.9) | < 0.001 |
Body mass index, kg/m2 | 23.7 ± 3.2 | 23.7 ± 3.2 | 22.6 ± 3.1 | < 0.001 |
Smoking status | ||||
Never | 2,983,062 (59.7) | 2,964,482 (59.7) | 18,580 (57.9) | < 0.001 |
Ex | 712,535 (14.2) | 707,910 (14.3) | 4625 (14.4) | |
Current | 1,304,969 (26.1) | 129,6097 (26.1) | 8872 (27.7) | |
Low income | 1,075,880 (21.5) | 78.5 (21.5) | 78.0 (22.0) | 0.026 |
Alcohol consumption | ||||
No | 2,585,695 (51.7) | 2,567,446 (51.7) | 18,249 (56.9) | < 0.001 |
Mild | 2,020,311 (40.4) | 2,009,501 (40.4) | 10,810 (33.7) | |
Heavy | 394,560 (7.9) | 391,542 (7.9) | 3018 (9.4) | |
Comorbid conditions | ||||
Diabetes mellitus | 436,055 (8.7) | 430,767 (8.7) | 5049 (15.7) | < 0.001 |
Hypertension | 1,350,494 (27.0) | 1,338,510 (26.9) | 11,904 (37.1) | < 0.001 |
Dyslipidemia | 909,576 (18.2) | 903,271 (18.2) | 6152 (19.2) | < 0.001 |
Heart disease | 99,770 (3.2) | 156,010 (3.1) | 1703 (5.3) | < 0.001 |
Stroke | 51,644 (1.6) | 80,986 (1.6) | 741 (2.3) | < 0.001 |
Chronic kidney disease, GFR < 30 mL/min/1.73 m2 | 72,882 (1.5) | 72,363(1.5) | 519 (1.6) | < 0.001 |
Asthma or COPD | 416,492 (8.3) | 411,887 (8.3) | 4689 (14.6) | < 0.001 |
Regular physical activity | 907,094 (18.1) | 901,780 (18.2) | 5533 (17.3) | < 0.001 |
Lipid profile | ||||
Total cholesterol level, mg/dL | 195.1 ± 36.8 | 195.1 ± 36.8 | 191.0 ± 37.9 | < 0.001 |
LDL cholesterol, mg/dL | 113.2 ± 33.9 | 113.2 ± 33.9 | 109.9 ± 34.8 | < 0.001 |
Triglycerides, mg/dL | 112.2 (112.2–112.3) | 112.2 (112.2–112.3) | 110.7 (110.1–111.4) | < 0.001 |
HDL cholesterol, mg/dL | 55.2 ± 17.3 | 55.2 ± 17.2 | 55.4 ± 21.5 | < 0.001 |
Statin use | 381,229 (7.6) | 378,101 (7.6) | 3153 (9.8) | < 0.001 |
